Antiplatelet properties of Pim kinase inhibition are mediated through disruption of thromboxane A2 receptor signaling. - Unsworth AJ; Bye AP; Sage T; Gaspar RS; Eaton N; Drew C; Stainer A; Kriek N; Volberding PJ; Hutchinson JL; Riley R; Jones S; et al. (Haematologica, 2021)